Search results
Results from the WOW.Com Content Network
A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date(s) one has received the shot(s) and the brand of vaccine one has received, sometimes including the lot number. The card also contains information identifying the recipient and the location where the shot was given.
The COVID-19 pandemic in Cambodia was a part of the ongoing worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first imported case in Cambodia was detected in Sihanoukville on 27 January 2020. [ 3 ]
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...
Cambodia reported one new case of the coronavirus on Sunday, bringing tally to 103 as the country prepares to tighten entry requirements for foreign nationals to try to curb the spread of the virus.
On 10 June, the WHO reported that research was continuing to determine how the COVID-19 virus can be transmitted by people who show no symptoms of the disease (asymptomatic transmission). [101] On 11 June, the WHO Africa regional office warned that COVID-19 was accelerating in Africa, with more than 200,000 cases and more than 5,600 deaths. [102]
“Those who have symptoms of a respiratory virus—cough, sneezing, body aches, nasal congestion with or without fever—should test for COVID-19—and influenza when influenza is circulating in ...
In August, China's National Intellectual Property Administration issued the country's first COVID-19 vaccine patent to CanSino. [34] On 16 May 2020, Canadian Prime Minister Justin Trudeau announced Health Canada had approved Phase II trials to be conducted by the Canadian Center for Vaccinology (CCfV) on the COVID-19 vaccine produced by CanSino.
The U.S. case count of mpox comprises roughly 14% of the total cases of clade I and II reported globally this year (21,370), per the CDC, while 11,911 cases have been reported in countries with ...